Press release from PR Newswire
Perrigo Company plc Announces Quarterly Dividend
Wednesday, January 29, 2014
Perrigo Company plc Announces Quarterly Dividend11:20 EST Wednesday, January 29, 2014
DUBLIN, Jan. 29, 2014 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on March 18, 2014 to shareholders of record on February 28, 2014.
From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquartered in Ireland, has grown to become a leading global healthcare supplier. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products and active pharmaceutical ingredients (API), and receives royalties from Multiple Sclerosis drug Tysabri®. The Company is the world's largest manufacturer of OTC healthcare products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo's mission is to offer uncompromised "Quality Affordable Healthcare Products?," and it does so across a wide variety of product categories primarily in the United States, United Kingdom, Mexico, Israel and Australia, as well as more than 40 other key markets worldwide, including Canada, China and Latin America. Visit Perrigo on the Internet (http://www.perrigo.com).
SOURCE Perrigo Company plc
For further information: Arthur J. Shannon, Vice President, Investor Relations and Global Communications (269) 686-1709; e-mail: firstname.lastname@example.org, or Bradley Joseph, Director, Investor Relations and Global Communications (269) 686-3373; e-mail: email@example.com